Literature DB >> 23508345

Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome).

Miguel A Rodriguez-Bigas1, Gabriela Möeslein.   

Abstract

The surgical management of the Lynch syndrome patient with colorectal cancer needs to be individualized. Because of the increased incidence of synchronous and metachronous colorectal neoplasms, most favor an extended resection at the time of diagnosis of colorectal cancer. Age of diagnosis, stage of the tumor, co-morbidities, surgical expertise, surgical morbidity, and patient wishes should be taken into account when considering a surgical procedure. There are no prospective randomized trials or retrospective trials suggesting that patients undergoing an extended procedure have a survival advantage compared to those undergoing segmental resection. In retrospective studies it has been demonstrated that patients undergoing extended procedures will develop less metachronous colorectal neoplasms and will undergo less subsequent surgical procedures related to colorectal cancer. In females abdominal hysterectomy and bilateral salpingoophorectomy should be considered at the time of surgery for colorectal cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23508345     DOI: 10.1007/s10689-013-9626-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  34 in total

1.  Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.

Authors:  Andreas Obermair; Danny R Youlden; Joanne P Young; Noralane M Lindor; John A Baron; Polly Newcomb; Susan Parry; John L Hopper; Robert Haile; Mark A Jenkins
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

2.  Comparison of extended colectomy and limited resection in patients with Lynch syndrome.

Authors:  Nagendra Natarajan; Patrice Watson; Edibaldo Silva-Lopez; Henry T Lynch
Journal:  Dis Colon Rectum       Date:  2010-01       Impact factor: 4.585

3.  Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.

Authors:  Wouter H de Vos tot Nederveen Cappel; Fokko M Nagengast; Gerrit Griffioen; Fred H Menko; Babs G Taal; Jan H Kleibeuker; Hans F Vasen
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

4.  Rectal cancer in hereditary nonpolyposis colorectal cancer.

Authors:  J S Lee; N J Petrelli; M A Rodriguez-Bigas
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

5.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.

Authors:  Susan Parry; Aung Ko Win; Bryan Parry; Finlay A Macrae; Lyle C Gurrin; James M Church; John A Baron; Graham G Giles; Barbara A Leggett; Ingrid Winship; Lara Lipton; Graeme P Young; Joanne P Young; Caroline J Lodge; Melissa C Southey; Polly A Newcomb; Loïc Le Marchand; Robert W Haile; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins
Journal:  Gut       Date:  2010-12-30       Impact factor: 23.059

6.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

7.  Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.

Authors:  Kathleen M Schmeler; Henry T Lynch; Lee-may Chen; Mark F Munsell; Pamela T Soliman; Mary Beth Clark; Molly S Daniels; Kristin G White; Stephanie G Boyd-Rogers; Peggy G Conrad; Kathleen Y Yang; Mary M Rubin; Charlotte C Sun; Brian M Slomovitz; David M Gershenson; Karen H Lu
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

8.  Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.

Authors:  S Syngal; J C Weeks; D Schrag; J E Garber; K M Kuntz
Journal:  Ann Intern Med       Date:  1998-11-15       Impact factor: 25.391

9.  Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

Authors:  Yvonne M C Hendriks; Anja Wagner; Hans Morreau; Fred Menko; Astrid Stormorken; Franz Quehenberger; Lodewijk Sandkuijl; Pal Møller; Maurizio Genuardi; Hans Van Houwelingen; Carli Tops; Marjo Van Puijenbroek; Paul Verkuijlen; Gemma Kenter; Anneke Van Mil; Hanne Meijers-Heijboer; Gita B Tan; Martijn H Breuning; Riccardo Fodde; Juul Th Wijnen; Annette H J T Bröcker-Vriends; Hans Vasen
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

10.  Surveillance in Lynch syndrome: how aggressive?

Authors:  S J Lanspa; J X Jenkins; R J Cavalieri; T C Smyrk; P Watson; J Lynch; H T Lynch
Journal:  Am J Gastroenterol       Date:  1994-11       Impact factor: 10.864

View more
  10 in total

1.  Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.

Authors:  Stacey A Cohen; Mercy Laurino; Deborah J Bowen; Melissa P Upton; Colin Pritchard; Fuki Hisama; Gail Jarvik; Alessandro Fichera; Britta Sjoding; Robin L Bennett; Lorraine Naylor; Angela Jacobson; Wylie Burke; William M Grady
Journal:  Cancer       Date:  2015-10-19       Impact factor: 6.860

Review 2.  The evolution of colorectal cancer genetics-Part 2: clinical implications and applications.

Authors:  Andrew T Schlussel; Ronald A Gagliano; Susan Seto-Donlon; Faye Eggerding; Timothy Donlon; Jeffrey Berenberg; Henry T Lynch
Journal:  J Gastrointest Oncol       Date:  2014-10

Review 3.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 4.  Current guidelines in the surgical management of hereditary colorectal cancers.

Authors:  Shantata Kudchadkar; Safia Ahmed; Tanmoy Mukherjee; Jayesh Sagar
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

5.  Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families.

Authors:  Tadeusz Dębniak; Tomasz Gromowski; Rodney J Scott; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Grzegorz Kurzawski; Dagmara Dymerska; Bohdan Górski; Katarzyna Paszkowska-Szczur; Cezary Cybulski; Pablo Serrano-Fernandez; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2015-01-16       Impact factor: 2.857

6.  Clinicopathological Features and Type of Surgery for Lynch Syndrome: Changes during the Past Two Decades.

Authors:  Il Tae Son; Duck-Woo Kim; Seung-Yong Jeong; Young-Kyoung Shin; Myong Hoon Ihn; Heung-Kwon Oh; Sung-Bum Kang; Kyu Joo Park; Jae Hwan Oh; Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2015-05-26       Impact factor: 4.679

7.  Deciding the operation type according to mismatch repair status among hereditary nonpolyposis colorectal cancer patients: should a tailored approach be applied, or does one size fit all?

Authors:  Chun-Kai Liao; Yueh-Chen Lin; Yu-Jen Hsu; Yih-Jong Chern; Jeng-Fu You; Jy-Ming Chiang
Journal:  Hered Cancer Clin Pract       Date:  2021-06-29       Impact factor: 2.857

Review 8.  The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.

Authors:  Stephanie A Cohen; Anna Leininger
Journal:  Appl Clin Genet       Date:  2014-07-22

9.  Efficacy, functional outcome and post-operative complications of total abdominal colectomy with ileorectal anastomosis vs. segmental colectomy in hereditary non-polyposis colorectal cancer.

Authors:  Jie Sun; Mingjie Dong; Xiaoping Xiao
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

10.  Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria.

Authors:  Ci-Yuan Sun; Jy-Ming Chiang; Tse-Ching Chen; Hsin-Yun Hung; Jeng-Fu You
Journal:  World J Surg Oncol       Date:  2020-08-07       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.